Mark O. DeNichilo
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
Papers in
-
- Cell Adhesion Molecules Research 4
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 6
- Immune cells in cancer 3
- Co-authors
- Jerry Yee (2 shared papers)Pedro Cortés (2 shared papers)Bruce L. Riser (2 shared papers)Robert G. Narins (1 shared paper)Carrie E. Brubaker (1 shared paper)Shinong Wang (1 shared paper)Raimund R. Hirschberg (1 shared paper)Andreas Evdokiou (12 shared papers)
- Journals
- Cancer Medicine (2 papers)Molecular Oncology (2 papers)International Journal of Oncology (2 papers)Kidney International (2 papers)Cancer Letters (2 papers)
- Partner nations
- AustraliaUnited StatesHong Kong
In The Last Decade
Mark O. DeNichilo
24 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 91
- Nephrology 180
- Clinical Biochemistry 72
- Rehabilitation 62
- Molecular Biology 652
- Pathology and Forensic Medicine 135
Countries citing papers authored by Mark O. DeNichilo
This map shows the geographic impact of Mark O. DeNichilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark O. DeNichilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark O. DeNichilo more than expected).
Fields of papers citing papers by Mark O. DeNichilo
This network shows the impact of papers produced by Mark O. DeNichilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark O. DeNichilo. The network helps show where Mark O. DeNichilo may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark O. DeNichilo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 346 | |
| 2 | 2001 | 184 | |
| 3 | 2001 | 109 | |
| 4 | 2008 | 106 | |
| 5 | 2003 | 86 | |
| 6 | 2017 | 53 | |
| 7 | 2014 | 42 | |
| 8 | 1991 | 36 | |
| 9 | 2015 | 33 | |
| 10 | 2015 | 29 | |
| 11 | 2021 | 27 | |
| 12 | 2016 | 27 | |
| 13 | 2016 | 22 | |
| 14 | 2014 | 19 | |
| 15 | 2015 | 15 | |
| 16 | 2021 | 15 | |
| 17 | 2016 | 15 | |
| 18 | 2009 | 12 | |
| 19 | 2017 | 10 | |
| 20 | Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs). | 2014 | 8 |
About Mark O. DeNichilo
Mark O. DeNichilo is a scholar working on Immunology and Allergy, Immunology, Cancer Research, Orthopedics and Sports Medicine and Molecular Biology, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), Connective Tissue Growth Factor Research (4 papers), Cell Adhesion Molecules Research (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Immune cells in cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Bone Metabolism and Diseases (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Nephrology (180 citations), Clinical Biochemistry (72 citations), Rehabilitation (62 citations), Molecular Biology (652 citations) and Pathology and Forensic Medicine (135 citations). Mark O. DeNichilo has collaborated with scholars based in Australia, United States and Hong Kong. Frequent co-authors include Jerry Yee, Pedro Cortés, Bruce L. Riser, Robert G. Narins, Carrie E. Brubaker, Shinong Wang, Raimund R. Hirschberg, Andreas Evdokiou, Vasilios Panagopoulos and Vasilios Liapis. Their work appears in journals such as Cancer Medicine, Molecular Oncology, International Journal of Oncology, Kidney International and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.